A new target of antiplatelet therapy: glycoprotein Ⅵ
Online published: 2015-08-27
Supported by
Shanghai Shen-Kang Technique Expansion Project, SHDC12012210; Baoshan District Science and Technology Commission Project, 12-E-63
Antiplatelet therapy plays a significant role in the treatment of cardiovascular disease. Now there are many drugs available for clinical application, but the curative effect is unsatisfactory. Complications such as bleeding are major problems. So it is urgent to find efficient and safe new drugs. Glycoprotein Ⅵ (GP Ⅵ) is one of the many receptors on platelet membrane and is also a new direction for developing antithrombotic drugs. This paper reviews studies relevant to GP Ⅵ.
Key words: glycoprotein Ⅵ; platelet; artery atherosclerotic
CHEN Yi-zhu , ZHANG Jun-feng . A new target of antiplatelet therapy: glycoprotein Ⅵ[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2015 , 35(7) : 1078 . DOI: 11.3969/j.issn.1674-8115.2015.07.027
/
〈 |
|
〉 |